HIV&AIDS: Symposium - Theme B - s100 prescriber session - Changing landscapes in Therapy
Tracks
1
| Wednesday, November 8, 2017 |
| 11:30 AM - 1:00 PM |
| Royal Theatre |
Details
This session will focus on issues pertinent to current prescribers including drug-drug interactions with new antiretrovirals, update on 2 drug regimens and strategies to minimise drug toxicity. Learning Objectives: Participants will gain knowledge on drug-drug interactions with newer agents such as cobicistat and tenofovir alefenamide, be updated on the current status of 2 drug antiretroviral regimens, identify situations where it is better to stop an antiretroviral causing a toxicity or continue the antiretroviral but treat the toxicity with an other method or drug, and be updated on polypharmacy for people with HIV from a large Australian cohort.
Speaker
Attendee506
Attendee1021
Dr Krista Siefried
Clinical Research Lead, Senior Lecturer, Deputy Director
National Centre for Clinical Research on Emerging Drugs
Dr Krista Siefried
Clinical Research Lead, Senior Lecturer, Deputy Director
National Centre for Clinical Research on Emerging Drugs
Attendee1236
